Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine

被引:24
|
作者
Gavillet, Mathilde [1 ]
Noetzli, Jasmine [1 ]
Blum, Sabine [1 ]
Duchosal, Michel A. [1 ]
Spertini, Olivier [1 ]
Lambert, Jean-Francois [1 ]
机构
[1] Univ Lausanne Hosp, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2012年 / 97卷 / 12期
关键词
5-azacytidine; acute myeloid leukemia; transfusion independence; survival; CONVENTIONAL CARE REGIMENS; LOW-DOSE CYTARABINE; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; TRIALS;
D O I
10.3324/haematol.2012.065151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1929 / 1931
页数:3
相关论文
共 50 条
  • [31] 5-AZACYTIDINE IN CHILDHOOD LEUKEMIA
    HRODEK, O
    VESELY, J
    NEOPLASMA, 1971, 18 (05) : 493 - &
  • [32] VINBLASTINE, 5-AZACYTIDINE, AND VP-16-213 THERAPY FOR PREVIOUSLY TREATED PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    VANECHO, DA
    LICHTENFELD, KM
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1977, 61 (08): : 1599 - 1602
  • [33] Sorafenib Combined with 5-azacytidine in Older Patients with Untreated FLT3-ITD Mutated Acute Myeloid Leukemia
    Ohanian, Maro
    Garcia-Manero, Guillermo
    Levis, Mark
    Jabbour, Elias
    Daver, Naval
    Borthakur, Gautam
    Kadia, Tapan
    Pierce, Sherry
    Burger, Jan
    Richie, Mary Ann
    Pater, Keyur
    Andreeff, Michael
    Estrov, Zeev
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : 1136 - 1141
  • [34] A Phase II Study of 5-Azacytidine (AZA) and Venetoclax As Maintenance Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias J.
    Alvarado, Yesid
    Chien, Kelly S.
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas J.
    Issa, Ghayas C.
    Jain, Nitin
    Ferrajoli, Alessandra
    Burger, Jan A.
    Linderman, Debra Bull
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2021, 138
  • [35] 5-Azacytidine to Treat Acute Myeloid Leukemia In Elderly or Frail Patients: A Phase II Study (SAKK 30/07).
    Passweg, Jakob R.
    Pabst, Thomas
    Blum, Sabine
    Bargetzi, Mario
    Sun, Hong
    Heim, Dominik
    Stussi, Georg
    Gregor, Michael
    Leoncini, Leda
    Meyer-Monard, Sandrine
    Brauchli, Peter
    Chalandon, Yves
    BLOOD, 2010, 116 (21) : 900 - 900
  • [36] TREATMENT OF ACUTE LEUKEMIA WITH 5-AZACYTIDINE (NSC-102816)
    MCCREDIE, KB
    BODEY, GP
    BURGESS, MA
    GUTTERMAN, JU
    RODRIGUEZ, V
    SULLIVAN, MP
    FREIREICH, EJ
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (03): : 319 - 323
  • [37] EFFECT OF SCHEDULE ON ACTIVITY OF 5-AZACYTIDINE IN ACUTE-LEUKEMIA
    SAIKI, J
    HEWLETT, J
    BODEY, G
    AMARE, M
    MORRISON, F
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 441 - 441
  • [38] 5-AZACYTIDINE (AZA) + AMSA FOR REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    LARSON, RA
    WINTER, JN
    KUCUK, O
    KWANN, H
    CLINICAL RESEARCH, 1984, 32 (04): : A753 - A753
  • [39] 5-AZACYTIDINE - NEW ACTIVE AGENT FOR TREATMENT OF ACUTE LEUKEMIA
    KARON, M
    SIEGER, L
    LEIMBROCK, S
    FINKLESTEIN, JZ
    NESBIT, ME
    SWANEY, JJ
    BLOOD, 1973, 42 (03) : 359 - 365
  • [40] Decrease in Transfusion Needs in Patients with Higher-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Treated with 5-Azacytidine. a Retrospective Study
    Diamantopoulos, Panagiotis Theodorou
    Zervakis, Konstantinos
    Galanopoulos, Athanasios G.
    Bakarakos, Panagiotis
    Papadopoulou, Vasiliki
    Iliakis, Theodoros
    Kalala, Fani
    Giannakopoulou, Nefeli
    Rougala, Niki
    Variami, Eleni
    Dimitrakopoulou, Aglaia
    Viniou, Nora-Athina
    BLOOD, 2014, 124 (21)